Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV) is the most common cause of respiratory tract infection in infants and children and shows increasing trend among elderly people worldwide. In many developing country settings, population and household structures have gone through some significant changes in the past...

Bibliográfalaš dieđut
Váldodahkkit:	Mahikul, W, White, L, Poovorawan, K, Soonthornworasiri, N, Sukontamarn, P, Chanthavilay, P, F Medley, G, Pan-Ngum, W
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Public Library of Science 2019

Geahča maid

Modeling household dynamics on Respiratory Syncytial Virus (RSV).
Dahkki: Wiriya Mahikul, et al.
Almmustuhtton: (2019-01-01)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis
Dahkki: Mahikul, W, et al.
Almmustuhtton: (2019)

A population dynamic model to assess the diabetes screening and reporting programs and project the burden of undiagnosed diabetes in Thailand
Dahkki: Mahikul, W, et al.
Almmustuhtton: (2019)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis.
Dahkki: Wiriya Mahikul, et al.
Almmustuhtton: (2019-05-01)

Pathobiology of Respiratory Syncytial Virus (RSV)
Dahkki: Ralph A. Tripp, et al.
Almmustuhtton: (2020-07-01)

Respiratory Syncytial Virus (RSV) Update
Dahkki: Leonard R. Krilov, et al.
Almmustuhtton: (2022-09-01)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
Dahkki: Kinyanjui, T, et al.
Almmustuhtton: (2020)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England and Wales and Finland: seasonality and cross-protection.
Dahkki: White, L, et al.
Almmustuhtton: (2005)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
Dahkki: Jackelyn Murray, et al.
Almmustuhtton: (2022-04-01)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection
Dahkki: White, L, et al.
Almmustuhtton: (2005)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
Dahkki: Dvir Gatt, et al.
Almmustuhtton: (2023-01-01)

Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
Dahkki: Pan-Ngum, W, et al.
Almmustuhtton: (2016)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
Dahkki: Timothy Kinyanjui, et al.
Almmustuhtton: (2020-04-01)

The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
Dahkki: Gengxin Zhang, et al.
Almmustuhtton: (2024-10-01)

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.
Dahkki: Shira Hirsh, et al.
Almmustuhtton: (2014-01-01)

Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination
Dahkki: Mohamad El Labban, et al.
Almmustuhtton: (2024-06-01)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
Dahkki: Mark R. Ackermann, et al.
Almmustuhtton: (2012-10-01)

Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
Dahkki: Samuel PC Brand, et al.
Almmustuhtton: (2020-03-01)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
Dahkki: Antepowicz, A, et al.
Almmustuhtton: (2018)

Monoterpene-Containing Substituted Coumarins as Inhibitors of Respiratory Syncytial Virus (RSV) Replication
Dahkki: Tatyana M. Khomenko, et al.
Almmustuhtton: (2021-12-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
Dahkki: Selir M. Straliotto, et al.
Almmustuhtton: (1994-03-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
Dahkki: Selir M. Straliotto, et al.
Almmustuhtton: (1994-03-01)

Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
Dahkki: Envera Lekic, et al.
Almmustuhtton: (2024-05-01)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
Dahkki: Andrea Gastaldi, et al.
Almmustuhtton: (2021-12-01)

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
Dahkki: Harrison C. Bergeron, et al.
Almmustuhtton: (2023-04-01)

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus
Dahkki: Sameer Joshi, et al.
Almmustuhtton: (2018-05-01)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
Dahkki: Anne M Hause, et al.
Almmustuhtton: (2017-01-01)

Model-based estimates of transmission of respiratory syncytial virus within households
Dahkki: Ivy K. Kombe, et al.
Almmustuhtton: (2019-06-01)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
Dahkki: Anne M Hause, et al.
Almmustuhtton: (2017-01-01)

Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
Dahkki: Patricia T. Campbell, et al.
Almmustuhtton: (2020-11-01)

New Inhibitors of Respiratory Syncytial Virus (RSV) Replication Based on Monoterpene-Substituted Arylcoumarins
Dahkki: Tatyana M. Khomenko, et al.
Almmustuhtton: (2023-03-01)

Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations
Dahkki: Drysdale, S, et al.
Almmustuhtton: (2020)

Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain
Dahkki: Sara Jimeno Ruiz, et al.
Almmustuhtton: (2024-11-01)

Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review
Dahkki: Anahita Poshtiban, et al.
Almmustuhtton: (2024-08-01)

Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
Dahkki: Xiao Li, et al.
Almmustuhtton: (2024-01-01)

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease
Dahkki: O'Hagan S, et al.
Almmustuhtton: (2023-09-01)

Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection.
Dahkki: H K Brand, et al.
Almmustuhtton: (2015-01-01)

Knowledge and Attitudes Regarding Respiratory Syncytial Virus (RSV) Prevention: A Systematic Review
Dahkki: Teresa Gavaruzzi, et al.
Almmustuhtton: (2025-02-01)

Resurgence of respiratory syncytial virus with dominance of RSV-B during the 2022–2023 season
Dahkki: Neli Korsun, et al.
Almmustuhtton: (2024-04-01)

The new reporting obligation for Respiratory Syncytial Virus (RSV) in Germany – a critical view
Dahkki: Heudorf, Ursel, et al.
Almmustuhtton: (2024-04-01)